CoChat

Suppression of inflammatory and immune responses by the A2Aadenosine receptor: an introduction

Open access
Palmer, T M, Trevethick, M A · 2008 · British Journal of Pharmacology
Cited by 68

The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.

Abstract

The purine nucleoside adenosine has been described as a ‘retaliatory metabolite’ by virtue of its ability to function in an autocrine manner to modify the activity of a range of cell types following its extracellular accumulation during cell stress or injury. These effects are largely protective and are triggered by the binding of adenosine to any of four G‐protein‐coupled adenosine receptors. Most of the anti‐inflammatory effects of adenosine have been assigned to the adenosine A 2A receptor subtype, which is expressed in many immune and inflammatory cells. In this brief article, we will outline the growing evidence to support the hypothesis that the development of agonists selective for the A 2A receptor is an effective strategy for suppressing the exaggerated inflammatory responses associated with many diseases by virtue of the receptor's ability to inhibit multiple pro‐inflammatory signalling cascades. British Journal of Pharmacology(2008)153, S27–S34; doi:10.1038/sj.bjp.0707524; published online 19 November 2007

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/sj.bjp.0707524

Cites

5 of 5 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 5 references

Cited by

Metadata

Authors
Palmer, T. M., & Trevethick, M. A.
Venue
British Journal of Pharmacology
Publisher
Wiley
Published
2008-03
Volume
153
Issue
S1
Pages
S27-34
ISSN
  • 0007-1188 (ISSN-L)
  • 1476-5381
OpenAlex
W1554232669
Cited by
68
References
5
FWCI
2.92
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.